Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting 2024-04-16 22:00
CryptoLab Signs a Contract to Supply Cutting-Edge Homomorphic Encryption Technology to Macrogen 2024-04-16 20:00
Wingderm® Shines Bright in the U.S.A., Continuously Expanding the Local Business Network 2024-04-16 17:22
Korea Zinc announces non-renewal of sulfuric acid consignment contract with Young Poong 2024-04-16 13:48
Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024 2024-04-16 02:00
First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trial 2024-04-15 20:30
Wound Care Plus, LLC Revolutionizes Wound Management with ARANZ Medical's Silhouette Solution 2024-04-15 20:00
DIGITAL THERAPEUTICS STARTUP RESPIREE™ ANNOUNCES INCORPORATION IN US WITH RESIDENCY AT JLABS @ SAN FRANCISCO 2024-04-15 14:15
【2024 AACR Late Breaking Research】TransThera announces clinical data of tinengotinib to treat patients with advanced solid tumors harboring actionable FGFR1-3 alterations 2024-04-12 21:00
Nuevocor Strengthens Leadership Team with Appointment of John Lee as Chief Medical Officer 2024-04-11 14:59
J INTS BIO, AACR 2024 - 'JIN-A02', a Novel Oral 4th Generation EGFR TKI, showing Clinical Benefits in the Ongoing Phase 1 Study 2024-04-11 14:56
ACROBiosystems Launches 3D Organoid Solutions, Propelling New Frontiers in Biotherapeutic Research 2024-04-10 21:00
Tsingke Showcases Cutting-Edge Biologics Solutions at Biologics 2024 2024-04-10 14:19
The Second International Conference on Single-cell and Spatial Omics (TICSSO-2) : showcasing the state-of-the-art bioscience achievements 2024-04-09 23:14
BioCity Announces FDA Clearance of the Investigational New Drug Application for its First-In-Class Antibody Drug Conjugate Targeting Glypican 3 2024-04-09 22:10
Datasea Announces Intent of its CEO to Purchase Up $3,000,000 of its Common Stock in Open Market Purchases 2024-04-09 22:00
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting 2024-04-09 19:59
GenFleet Therapeutics Announces Broad-spectrum Activity of GFH547, an Oral panRAS (ON) Inhibitor, and Its Potential to Overcome Resistance against SIIP-based KRAS Inhibitors in Late-breaking Research Abstract of 2024 AACR Annual Meeting 2024-04-09 19:00
GenFleet Therapeutics Announces Potent Anti-tumor Efficacy of GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor, and its Potential in Combination Therapy with RAF/MEK Clamp at 2024 AACR Annual Meeting 2024-04-09 19:00
Abbisko Completed All Patient Enrollment for The Global Phase III TGCT Trial of Its CSF-1R Inhibitor - Pimicotinib 2024-04-09 08:30
1 31 32 33 34 35 431